RALEIGH, NC--(Marketwired - June 18, 2013) - DARA BioSciences, Inc. (DARA), a specialty pharmaceutical company focused on oncology supportive care products, announced today that it has granted T3D ...

There’s a growing consensus that two of society’s most rampant public health issues – Type II Diabetes and Alzheimer’s disease – are intertwined. It’s not all about clearing plaques anymore: Insulin ...

Dara BioSciences said today it granted exclusive worldwide rights to develop and commercialize its DB959 to T3D Therapeutics, which will reposition the experimental drug to fight Alzheimer’s disease.

RESEARCH TRIANGLE PARK, NC / ACCESSWIRE / April 20, 2021 / T3D Therapeutics, Inc. ("T3D"), a clinical stage drug development company engaged in the development of T3D-959, a new orally administered ...

A small Research Triangle Park drug developer founded by a former GlaxoSmithKline executive thinks it has a way to fight Alzheimer’s, a disease that has for years frustrated drug developers big and ...

Anyone searching for an affordable portable multifunctional 3D printer capable of generating high quality small form factor prints may be interested in the T3D created by a team based in San Francisco ...